XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.3
Accrued Expenses and Other Liabilities (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Accrued Expenses and Other Liabilities    
Accrued marketing expenses $ 1,001,439 $ 1,013,497
Other expenses 203,389 313,254
Accrued preclinical and clinical trial expenses 364,460 405,792
Compensation and related benefits 595,450 332,641
Accrued manufacturing expenses 4,360 97,877
Advance payments received from customers for manufacturing materials 169,758  
Accrued franchise tax   38,800
Accrued expenses and other current liabilities $ 2,338,856 $ 2,201,861